Echo Aids Diagnosis, Risk Prediction in Severe COVID-19
Transthoracic echo, particularly point-of-care devices, should not be overlooked in patients with suspected cardiac involvement
Transthoracic echo, particularly point-of-care devices, should not be overlooked in patients with suspected cardiac involvement
Several surgeons told TCTMD they’re highly critical of the trend, saying it’s time for an RCT of TAVI vs SAVR in those below age 65.
The conclusion is consistent with the FDA’s review of the issue.
If the LV is likely to improve or normalize with TAVI, there’s no reason not to treat, says Guy Witberg. But for some TAVI might…
As a slew of new catheter-based devices hit the market, it will be crucial to keep tabs on eligibility, safety, and access, experts say.
Black, Hispanic, and white sexual-minority women each have distinct risk profiles, speaking to the need for tailored care.
Interventionalists say it’s now time to make a dent in the complication rate, whether by strict protocols or smaller devices.
Even at a mean age of 85 years, there is still time to accrue mortality benefits from potent LDL-lowering therapies.
The three calculators focus on isolated tricuspid repair and replacement, SAVR after TAVI, and multivalve procedures.
Lower risks of death and MACE in statin users are intriguing, but need to be confirmed in randomized trials, experts say.
Jeffrey Carson and Serge Korjian discuss restrictive versus liberal blood transfusion in patients with MI and anemia.